| Typicality: | 0.345 |
| Saliency: | 0.222 |
| in myelodysplastic syndromes | 5 | other |
| mutation → be associated with → poorer outcomes | 3 |
| mutation → be associated with → better outcomes | 3 |
| mutation → correlate with → patient outcome | 3 |
| negative | neutral | positive |
| 0.271 | 0.624 | 0.104 |
| Raw frequency | 9 |
| Normalized frequency | 0.222 |
| Modifier score | 0.500 |
| Perplexity | 234.580 |